Pathogenesis of COVID-19 mediated Cardiovascular Complications: Therapeutic Applications

COVID-19 介导的心血管并发症的发病机制：治疗应用

• 批准号: 433317
• 负责人: Oudit Gavin Y
• 金额: $ 63.81万
• 依托单位: University of Alberta
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2020
• 资助国家: 加拿大
• 起止时间: 2020-10-01 至 2025-10-01
• 项目状态: 未结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=433317&lang=en
• 关键词: Cytokines; Renin-Angiotesnin System; Sars-Cov-2

COVID-19, caused by SARS-CoV-2 has caused a worldwide pandemic. Male patients have a worse outcome compared to the females. COVID-19 infection leads to SARS but the cardiovascular (CV) system is also highly involved. This is because the molecule that medi

由SARS-CoV-2引起的COVID-19已引起全球大流行。与女性相比，男性患者的结局更差。COVID-19感染导致SARS，但心血管（CV）系统也高度参与。这是因为，